Overview
| Specialty |
Renal Transplantation
|
| Clinical Interests |
Nephrology |
| |
Renal Disease |
| |
Kidney Disorders |
| Languages |
English |
| Gender |
Female |
| E-mail |
vinita.sehgal@mssm.edu |
| Education and Training |
MD, Yale University School of Medicine |
| |
Residency, Internal Medicine, Columbia-Presbyterian Medical Ctr. |
| |
Fellowship, Nephrology Transplant, Columbia-Presbyterian Medical Ctr. |
| |
Fellowship, Nephrology, Columbia-Presbyterian Medical Ctr. |
Dr. Sehgal earned her M.D. at Yale University School of Medicine and
went on to do her residency in Internal Medicine at
Columbia-Presbyterian Medical Center here in New York City. She
completed a fellowship in Nephrology and a fellowship in Transplant
Nephrology also at Columbia-Presbyterian. Among her many honors, Dr.
Sehgal was recognized as a John Harvard Scholar at Harvard University
in 1986 where she graduated Cum Laude. Dr. Sehgal is board certified in
Internal Medicine and Nephrology.
Dr. Sehgal's society
memberships include the American Society of Nephrology, American
College of Physicians and the New York State Society of Nephrology.
Curriculum Vitae:
http://www.mountsinai.org/supporting-files/cv/sehg...
Research
Transplant nephrology
Clinical research interest in the medical complications of
transplantation, including hepatitis C, post-transplant diabetes, bone
disease, and hypercoagulable states.
Publications
Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation:cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995; 26(1): 193-201.
Goldstein DI, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen DJ. Cyclosporine-associated end-stage nephropathy after cardiac transplantation:incidence and progression. Transplantation 1997; 63(5): 664-668.
Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS. Intravenous Immunoglobulin and thymoglobulin facilitate kidney transplantation in complement dependent cytotoxicity B cell and flow cytometry (T and/or B cell) cross-match positive patients. Transplantation 2003; 76(10): 1444-1447.
Akalin E, Sehgal V, Ames S, Hossain S, Daly L, Murphy B, Bromberg JS. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. American Journal of Transplantation 2003; 3(6): 731-735.
